CellaVision AB (publ) CEVI.ST Stock
CellaVision AB (publ) Price Chart
CellaVision AB (publ) CEVI.ST Financial and Trading Overview
CellaVision AB (publ) stock price | 221.5 SEK |
Previous Close | 196 SEK |
Open | 202 SEK |
Bid | 196.2 SEK x 0 |
Ask | 197.6 SEK x 0 |
Day's Range | 196 - 202 SEK |
52 Week Range | 151.6 - 394.5 SEK |
Volume | 612 SEK |
Avg. Volume | 18.77K SEK |
Market Cap | 4.71B SEK |
Beta (5Y Monthly) | 0.995402 |
PE Ratio (TTM) | 43.620308 |
EPS (TTM) | 5.47 SEK |
Forward Dividend & Yield | 2.25 (1.14%) |
Ex-Dividend Date | May 8, 2023 |
1y Target Est | 202.5 SEK |
CEVI.ST Valuation Measures
Enterprise Value | 4.67B SEK |
Trailing P/E | 43.620308 |
Forward P/E | 29.016153 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 7.6508923 |
Price/Book (mrq) | 7.094898 |
Enterprise Value/Revenue | 7.578 |
Enterprise Value/EBITDA | 30.047 |
Trading Information
CellaVision AB (publ) Stock Price History
Beta (5Y Monthly) | 0.995402 |
52-Week Change | -34.99% |
S&P500 52-Week Change | 20.43% |
52 Week High | 394.5 SEK |
52 Week Low | 151.6 SEK |
50-Day Moving Average | 184.02 SEK |
200-Day Moving Average | 227.3 SEK |
CEVI.ST Share Statistics
Avg. Volume (3 month) | 18.77K SEK |
Avg. Daily Volume (10-Days) | 16.35K SEK |
Shares Outstanding | 23.85M |
Float | 19.52M |
Short Ratio | N/A |
% Held by Insiders | 38.15% |
% Held by Institutions | 41.54% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.25 |
Trailing Annual Dividend Yield | 1.14% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.48080003 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 16.09% |
Operating Margin (ttm) | 21.66% |
Gross Margin | 68.10% |
EBITDA Margin | 25.21% |
Management Effectiveness
Return on Assets (ttm) | 9.55% |
Return on Equity (ttm) | 15.87% |
Income Statement
Revenue (ttm) | 616.01M SEK |
Revenue Per Share (ttm) | 25.83 SEK |
Quarterly Revenue Growth (yoy) | -14.39% |
Gross Profit (ttm) | 438.32M SEK |
EBITDA | 155.35M SEK |
Net Income Avi to Common (ttm) | 99.14M SEK |
Diluted EPS (ttm) | 4.53 |
Quarterly Earnings Growth (yoy) | -50.00000000000000000000000000000000% |
Balance Sheet
Total Cash (mrq) | 93.07M SEK |
Total Cash Per Share (mrq) | 3.9 SEK |
Total Debt (mrq) | 95.62M SEK |
Total Debt/Equity (mrq) | 14.4 SEK |
Current Ratio (mrq) | 3.018 |
Book Value Per Share (mrq) | 27.851 |
Cash Flow Statement
Operating Cash Flow (ttm) | 117.96M SEK |
Levered Free Cash Flow (ttm) | 2.56M SEK |
Profile of CellaVision AB (publ)
Country | Sweden |
State | N/A |
City | Lund |
Address | Mobilvägen 12 |
ZIP | 223 62 |
Phone | 46 4 64 60 16 00 |
Website | https://www.cellavision.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 235 |
CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. Further, it offers reagents to identify cell and tissue morphology, parasites, and bacteria in diagnosing various diseases; and instruments, including RAL SmearBox, RAL Stainbox, and RAL Stainer. The company sells its products to hospital and commercial laboratories. The company was incorporated in 1994 and is headquartered in Lund, Sweden.
Q&A For CellaVision AB (publ) Stock
What is a current CEVI.ST stock price?
CellaVision AB (publ) CEVI.ST stock price today per share is 221.5 SEK.
How to purchase CellaVision AB (publ) stock?
You can buy CEVI.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CellaVision AB (publ)?
The stock symbol or ticker of CellaVision AB (publ) is CEVI.ST.
Which industry does the CellaVision AB (publ) company belong to?
The CellaVision AB (publ) industry is Medical Devices.
How many shares does CellaVision AB (publ) have in circulation?
The max supply of CellaVision AB (publ) shares is 23.85M.
What is CellaVision AB (publ) Price to Earnings Ratio (PE Ratio)?
CellaVision AB (publ) PE Ratio is 40.49360300 now.
What was CellaVision AB (publ) earnings per share over the trailing 12 months (TTM)?
CellaVision AB (publ) EPS is 5.47 SEK over the trailing 12 months.
Which sector does the CellaVision AB (publ) company belong to?
The CellaVision AB (publ) sector is Healthcare.
CellaVision AB (publ) CEVI.ST included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
OMX_Stockholm_Mid_Cap_PI OMXSMCPI | 1516.78 SEK 148.06 USD |
-0.02
|
— — | — — | — — | — - | — — |
OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
OMX_Nordic_Mid_Cap_SEK_GI OMXNMCSEKGI | 548.69 SEK 53.56 USD |
+0.07
|
— — | — — | — — | — - | — — |
OMX_Nordic_Mid_Cap_EUR_GI OMXNMCEURGI | 439.19 EUR 480.1 USD |
-0.42
|
— — | — — | — — | — - | — — |
OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
OMX Stockholm Health Care Equip SX4530GI | 1816.79 SEK 177.34 USD |
<0.01
|
— — | — — | — — | — - | — — |
NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2564.43 SEK 250.32 USD |
-0.59
|
— — | — — | — — | — - | — — |
OMX Stockholm Health Care PI SX20PI | 3276.93 SEK 319.87 USD |
-0.07
|
— — | — — | — — | — - | — — |
OMX Stockholm Medical Equipment SX201020PI | 1557.67 SEK 152.05 USD |
-1.1
|
— — | — — | — — | — - | — — |
OMX Stockholm_PI OMXSPI | 947.32 SEK 92.47 USD |
-0.04
|
— — | — — | — — | — - | — — |
OMX_Stockholm_Mid_Cap_GI OMXSMCGI | 796.9 SEK 77.79 USD |
-0.02
|
— — | — — | — — | — - | — — |
OMX Stockholm All-Share Cap_GI OMXSCAPGI | 456.92 SEK 44.6 USD |
+0.02
|
— — | — — | — — | — - | — — |
OMX_Nordic_Mid_Cap_ISK_GI OMXNMCISKGI | 622.38 ISK 4.58 USD |
-0.43
|
— — | — — | — — | — - | — — |
OMX_Nordic_Mid_Cap_DKK_GI OMXNMCDKKGI | 439.38 DKK 64.42 USD |
-0.4
|
— — | — — | — — | — - | — — |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}